The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer

被引：2
|
作者：
Chen, Yen-Yin [1 ,2 ,3 ,4 ]
Yang, Ching-Fe [3 ,4 ]
Hsu, Chih-Yi [3 ,4 ,5 ]
机构：
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[5] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan
来源：
PATHOLOGY | 2024年 / 56卷 / 01期
关键词：
EXPRESSION; FIXATION;
D O I：
10.1016/j.pathol.2023.06.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：122 / 124
页数：3
相关论文
共 50 条
  • [41] The frequency of HER2 amplification and the percentage of membrane staining in HER2 2+invasive carcinomas of the breast Reply
    Polonia, Antonio
    Canelas, Carolina
    Caramelo, Ana
    VIRCHOWS ARCHIV, 2022, 481 (02) : 329 - 330
  • [42] Breast HER2 Insitu Hybridization (HER2 ISH): Acceptable and unacceptable staining criteria impacting on interpretation
    Parry, S.
    Miller, K.
    Ibrahim, M.
    VIRCHOWS ARCHIV, 2012, 461 : S258 - S258
  • [43] HER2-low Breast Cancers: Comparison of HER2 Scores by Immunohistochemistry and Oncotype DX
    Chen, Hui
    Wu, Yun
    Ding, Qingqing
    Huo, Lei
    Khazai, Laila
    Sahin, Aysegul
    Albarracin, Constance
    LABORATORY INVESTIGATION, 2023, 103 (03) : S114 - S114
  • [44] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, S.
    Lee, S. H.
    Lee, H. J.
    Jeong, H.
    Jeong, J-H.
    Kim, J. E.
    Ahn, J-H.
    Jung, K. H.
    Kim, H. H.
    Lee, S.
    Lee, J.
    Kim, S-B.
    ANNALS OF ONCOLOGY, 2023, 34 : S305 - S305
  • [45] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, Sora
    Lee, So Heun
    Lee, Hee Jin
    Jeong, Hyehyun
    Jeong, Jae Ho
    Kim, Jeong Eun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Gong, Gyungyub
    Kim, Hak Hee
    Lee, Saebyeol
    Lee, Jongwon
    Kim, Sung-Bae
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [46] Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer
    Li, Xiaoxian
    Zhao, Jing
    Zhang, Chao
    Li, Zaibo
    LABORATORY INVESTIGATION, 2019, 99
  • [47] Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer
    Li, Xiaoxian
    Zhao, Jing
    Zhang, Chao
    Li, Zaibo
    MODERN PATHOLOGY, 2019, 32
  • [48] Analysis of HER2 distribution concordance in breast cancer tissue by serial IHC staining
    Peng, G-R.
    Ye, C-H.
    Lee, J. Y. C.
    Hu, S.
    Yu, W-C.
    Lin, W-C.
    Yu, S-H.
    ANNALS OF ONCOLOGY, 2021, 32 : S374 - S374
  • [49] HER2 positivity in advanced gastric cancer:: Variation in histopathological staining compared to breast cancer
    Rueschoff, J.
    Henkel, T.
    Stoss, O.
    Bang, Y. J.
    Van Cutsem, E.
    Gross, C.
    Kaufmann, M.
    LABORATORY INVESTIGATION, 2008, 88 : 133A - 133A
  • [50] HER2 positivity in advanced gastric cancer:: Variation in histopathological staining compared to breast cancer
    Rueschoff, J.
    Henkel, T.
    Sloss, O.
    Bang, Y. J.
    Van Culsem, E.
    Gross, C.
    Kaufmann, M.
    MODERN PATHOLOGY, 2008, 21 : 133A - 133A
12345